As global markets experience mixed returns and investors navigate a complex economic landscape, the Hong Kong market remains a focal point for those seeking resilient investment opportunities. Amid these dynamics, dividend stocks offer a potential avenue for stability and income, making them particularly attractive in uncertain times. In this article, we will explore three dividend stocks listed on the Stock Exchange of Hong Kong (SEHK), including Stella International Holdings. Understanding what makes a good dividend stock—such as consistent earnings, strong cash flow, and sustainable payout ratios—can help investors make informed decisions in today's market environment.
Overview: Stella International Holdings Limited is an investment holding company involved in the development, manufacture, and sale of footwear products and leather goods across North America, China, Europe, Asia, and internationally with a market cap of HK$10.57 billion.
Operations: Stella International Holdings Limited generates revenue primarily from its Manufacturing segment at $1.49 billion and from its Retailing and Wholesaling segment at $4.61 million.
Dividend Yield: 7.9%
Stella International Holdings has demonstrated a mixed dividend performance over the past decade, with payments being volatile yet showing some growth. Despite this instability, dividends are reasonably covered by earnings (74.1% payout ratio) and cash flows (61.6% cash payout ratio). Recent guidance indicates robust profit growth, with net profits expected to reach US$90 million for H1 2024 compared to US$55.2 million in H1 2023, supported by a revenue increase of approximately 7.5%.
Overview: China Kepei Education Group Limited, with a market cap of HK$2.90 billion, provides private vocational education services focusing on profession-oriented and vocational education in China.
Operations: China Kepei Education Group Limited generates CN¥1.60 billion from its provision of education services.
Dividend Yield: 9.7%
China Kepei Education Group's dividend yield is among the top 25% in Hong Kong, but its short and volatile dividend history raises concerns. Despite this, dividends are well covered by earnings (16.7% payout ratio) and cash flows (33.9% cash payout ratio). The company trades at a significant discount to its estimated fair value, indicating potential for capital appreciation. Recent executive changes may impact future financial stability and strategic direction.
Overview: IVD Medical Holding Limited, with a market cap of HK$1.54 billion, distributes in vitro diagnostic (IVD) products in Mainland China and internationally.
Operations: IVD Medical Holding Limited generates revenue from three main segments: After-sales services (CN¥179.37 million), Distribution Business (CN¥2.90 billion), and Self-Branded Products Business (CN¥10.62 million).
Dividend Yield: 9.6%
IVD Medical Holding's dividend yield ranks in the top 25% of Hong Kong payers, but its short and volatile history is a concern. Dividends are well covered by earnings (47.3% payout ratio) and cash flows (54.7% cash payout ratio). The company trades at a significant discount to estimated fair value, suggesting potential upside. Recent board changes and a follow-on equity offering of HK$189.64 million may impact future dividend stability and shareholder value.
Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SEHK:1836 SEHK:1890 and SEHK:1931.
